Search is Powered by Google
Cancer / Oncology News

Improving Diagnosis Of Cancer By Detecting Protein Sugar Structures

Main Category: Cancer / Oncology
Also Included In: Blood / Hematology;  Biology / Biochemistry
Article Date: 06 Oct 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Researchers report in the October 2007 issue of Molecular & Cellular Proteomics that they have developed a new way of detecting the abnormal presence of complexes of sugars and proteins in the blood of cancer patients, thus providing a new tool for cancer diagnosis.

Many proteins on the surface of cells have sugars attached to them, which helps the cells bind with one another and communicate among one another. But in cancer, these cell surface proteins can have an abnormally high number of sugar molecules attached to them.

Martin R. Larsen and colleagues report a method that uses titanium dioxide to isolate the parts of the cell surface proteins that are attached to sialic acid, which is the "outside" portion of some of the sugars that are attached to these proteins. The method was used to compare the number of protein-sugar structures that contain sialic acid in the blood plasma of a control individual and a patient with advanced bladder cancer. The scientists showed that the cancer patient's blood contained a significantly higher number of these sialic acid-containing structures than the control individual.

This method is a promising way to diagnose cancer and other diseases with excess sialic acid-containing protein-sugar structures, the scientists conclude.

Article: "Exploring the Sialiome Using Titanium Dioxide Chromatography and Mass Spectrometry," by Martin R. Larsen, Soren S. Jensen, Lene A. Jakobsen, and Niels H.H. Heegaard

The American Society for Biochemistry and Molecular Biology is a nonprofit scientific and educational organization with over 11,900 members in the United States and internationally. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, nonprofit research institutions and industry. The Society's student members attend undergraduate or graduate institutions.

Founded in 1906, the Society is based in Bethesda, Maryland, on the campus of the Federation of American Societies for Experimental Biology. The Society's purpose is to advance the science of biochemistry and molecular biology through publication of the Journal of Biological Chemistry, the Journal of Lipid Research, and Molecular and Cellular Proteomics, organization of scientific meetings, advocacy for funding of basic research and education, support of science education at all levels, and promoting the diversity of individuals entering the scientific work force.

For more information about ASBMB, see the Society's Web site at http://www.asbmb.org.

American Society for Biochemistry and Molecular Biology (ASBMB)
9650 Rockville Pike
Bethesda, MD 20814-3996
United States
http://www.asbmb.org




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...